Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are employed to...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Introduction to Statistical Process Control01:15

Introduction to Statistical Process Control

Statistical Process Control (SPC) is a method used to monitor and control quality within processes, particularly in manufacturing and service delivery, by employing statistical methods. SPC aims to distinguish between natural (common cause) variation and variation due to specific changes or events (special cause), allowing for timely improvements and sustained quality. The control chart, a pivotal tool in SPC, visually displays data over time alongside a central line of upper and lower control...
Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measuring What Matters to Children With Medical Complexity and Their Families.

Pediatrics·2024
Same author

Trends in Diagnosis of Noninvasive Follicular Thyroid Neoplasm With Papillarylike Nuclear Features and Total Thyroidectomies for Patients With Papillary Thyroid Neoplasms.

JAMA otolaryngology-- head & neck surgery·2021
Same author

Disparities in the use of antenatal corticosteroids among women with hypertension in North Carolina.

Journal of perinatology : official journal of the California Perinatal Association·2019
Same author

88<sup>th</sup>Annual Meeting of the American Thyroid Association October 3-7, 2018 Marriott Marquis, Washington, DC.

Thyroid : official journal of the American Thyroid Association·2018
Same author

The National Network of State Perinatal Quality Collaboratives: A Growing Movement to Improve Maternal and Infant Health.

Journal of women's health (2002)·2018
Same author

The National Network of State Perinatal Quality Collaboratives: A Growing Movement to Improve Maternal and Infant Health.

Journal of women's health (2002)·2018

Related Experiment Video

Updated: Jun 11, 2026

Extraction and Characterization of Surfactants from Atmospheric Aerosols
09:34

Extraction and Characterization of Surfactants from Atmospheric Aerosols

Published on: April 21, 2017

Using quality-improvement methods to reduce variation in surfactant administration.

Laurel Bookman1, Rachel Troy, Martin McCaffrey

  • 1Division of Neonatology, Cincinnati Children's Hospital, MLC 7009, 3333 Burnet Avenue, Cincinnati, OH 45209, USA. laurelmed1@yahoo.com

Quality & Safety in Health Care
|July 3, 2010
PubMed
Summary

Quality improvement methods significantly reduced the time to surfactant administration for premature infants. This enhanced timely treatment for respiratory distress syndrome in extremely low-birth-weight infants.

More Related Videos

A Cost-effective and Reliable Method to Predict Mechanical Stress in Single-use and Standard Pumps
07:34

A Cost-effective and Reliable Method to Predict Mechanical Stress in Single-use and Standard Pumps

Published on: August 5, 2015

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

Related Experiment Videos

Last Updated: Jun 11, 2026

Extraction and Characterization of Surfactants from Atmospheric Aerosols
09:34

Extraction and Characterization of Surfactants from Atmospheric Aerosols

Published on: April 21, 2017

A Cost-effective and Reliable Method to Predict Mechanical Stress in Single-use and Standard Pumps
07:34

A Cost-effective and Reliable Method to Predict Mechanical Stress in Single-use and Standard Pumps

Published on: August 5, 2015

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

Area of Science:

  • Neonatal care
  • Quality improvement science
  • Respiratory medicine

Background:

  • Respiratory distress syndrome and chronic lung disease are common in extremely low-birth-weight infants.
  • Timely surfactant administration is crucial for improving respiratory outcomes in these vulnerable infants.

Purpose of the Study:

  • To evaluate the effectiveness of basic quality improvement methods in reducing the time to initial surfactant dose for premature infants.
  • To assess the impact of process changes on surfactant delivery timeliness.

Main Methods:

  • The study utilized Plan-Do-Study-Act cycles in a 48-bed neonatal intensive care unit (NICU).
  • Intervention involved surfactant administration in the delivery room with a dedicated respiratory therapist.
  • Data collected on infants born less than 27 weeks gestation.

Main Results:

  • Surfactant was administered in the delivery room for 95% of eligible infants post-intervention.
  • The mean time to initial surfactant dose decreased from 26 minutes to 10.2 minutes (p=0.0004).
  • Variation in the timing of surfactant administration was also reduced.

Conclusions:

  • Quality improvement initiatives can effectively enhance the timeliness of surfactant administration in NICUs.
  • These methods successfully reduced variability in treatment timing for premature infants.
  • Further research is recommended to validate these findings across diverse NICU settings.